Ultragenyx Pharmaceutical, Inc. (RARE)

23.39 +0.35 (+1.52%) USD  |  NASDAQ  |  Feb 27, 16:00
22.66 -0.73 (-3.12%) After-Hours: 20:00
More

Ultragenyx Pharmaceutical Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
CorMedix, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade